Related Experiment Video
Updated: Sep 24, 2025
07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
558
Novel Biomarkers in Membranous Nephropathy
Qiuying Liu1,2, Jianhua Liu1, Baoxu Lin1
1Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Frontiers in Immunology
|May 9, 2022
Summary
New biomarkers are improving the diagnosis and treatment of membranous nephropathy (MN), a leading cause of nephrotic syndrome. Research highlights phospholipase A2 receptor (PLA2R) and other novel markers for better patient outcomes.
Area of Science:
- Nephrology and Immunology
- Biomarker Discovery
Background:
- Membranous nephropathy (MN) is a primary cause of adult nephrotic syndrome (NS), characterized by immune complex deposition.
- A significant portion of MN patients progress to end-stage renal disease (ESRD), emphasizing the need for timely diagnosis and intervention.
- Current understanding of MN pathogenesis is evolving, driving research into novel diagnostic and prognostic tools.
Purpose of the Study:
- To review recent advancements in the identification of biomarkers for membranous nephropathy.
- To highlight the clinical significance of established and emerging biomarkers in MN diagnosis, prognosis, and treatment.
Main Methods:
- Review of high-throughput technologies including mass spectrometry, microarrays, and sequencing.
- Analysis of reported podocyte target antigens and their autoantibodies.
- Synthesis of findings on novel biomarkers such as proteins, metabolites, noncoding RNAs (ncRNAs), and immune cells.
Main Results:
- Phospholipase A2 receptor (PLA2R) and its autoantibodies are well-established biomarkers with diagnostic and therapeutic value in MN.
- Emerging biomarkers across various categories (proteins, metabolites, ncRNAs, immune cells) show promise for MN management.
- Biomarker discovery is crucial for understanding MN progression and treatment response.
Conclusions:
- Significant progress has been made in identifying biomarkers for membranous nephropathy.
- These biomarkers are vital for improving the diagnosis, monitoring progression, predicting prognosis, and guiding treatment strategies for MN.
- Continued research into novel biomarkers holds great potential for enhancing patient care in MN.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
32
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
32
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
236
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
236
01:24Nephrotic Syndrome I : Introduction
41
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
41
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
371
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
371